These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9379618)

  • 1. [5-alpha-reductase inhibitors in benign prostatic hyperplasia].
    Panchev P; Neĭkov K
    Khirurgiia (Sofiia); 1997; 50(1):41-3. PubMed ID: 9379618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Benign prostatic hyperplasia--its treatment with Proscar].
    Panchev P; Neĭkov K; Simeonov P
    Khirurgiia (Sofiia); 1996; 49(1):15-8. PubMed ID: 8975081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The treatment of patients with benign prostatic hyperplasia with Proscar MSD (finasteride)].
    Stepanov VN; Teodorovich OV; Seregin AV; Kadyrov ZA
    Urol Nefrol (Mosk); 1995; (5):28-30. PubMed ID: 8571480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Proscar (finasteride, MSD) in the treatment of patients with prostatic hyperplasia].
    Pytel' IuA; Vinarov AZ
    Urol Nefrol (Mosk); 1996; (4):25-7. PubMed ID: 8928344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of finasteride in the treatment of symptomatic benign prostatic hyperplasia.
    Wu TT; Lee YH; Jiaan BP; Huang JK
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Dec; 56(6):399-403. PubMed ID: 8851481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Using doxasosine and finasteride combination in the treatment of prostate adenoma].
    Bogdanov AB; Luk'ianov IV; Veliev EI
    Urologiia; 2006; (5):59-63. PubMed ID: 17444154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group.
    Gormley GJ; Stoner E; Bruskewitz RC; Imperato-McGinley J; Walsh PC; McConnell JD; Andriole GL; Geller J; Bracken BR; Tenover JS
    N Engl J Med; 1992 Oct; 327(17):1185-91. PubMed ID: 1383816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of terazosin and finasteride in symptomatic benign prostatic hyperplasia: A comparative study.
    Anwarul Islam AK; Kashem MA; Shameem IA; Kibria SA
    Bangladesh Med Res Counc Bull; 2005 Aug; 31(2):54-61. PubMed ID: 16967810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A trial of the use of finasteride and terazosin in patients with benign prostatic hyperplasia].
    Pushkar' DIu; Kosko DV; Loran OB; Kan IaD; Sapozhnikov IM; Tevlin KP
    Urol Nefrol (Mosk); 1995; (4):32-5. PubMed ID: 7571199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of long-term administration of finasteride (MK-906), an inhibitor of 5 alpha-reductase, in patients with benign prostatic hyperplasia.
    Yoshida O; Oishi K; Okada Y; Mizutani Y; Itokawa Y; Tomoyoshi T; Okada K; Komatz Y; Matsuda T; Takeuchi H
    Hinyokika Kiyo; 1996 Apr; 42(4):323-31. PubMed ID: 8693970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.
    Lepor H; Williford WO; Barry MJ; Brawer MK; Dixon CM; Gormley G; Haakenson C; Machi M; Narayan P; Padley RJ
    N Engl J Med; 1996 Aug; 335(8):533-9. PubMed ID: 8684407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The current principles of the conservative treatment of patients with benign prostatic hypertrophy].
    Ianev V; Milushev N
    Khirurgiia (Sofiia); 1994; 47(3):36-8. PubMed ID: 8531430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group.
    McConnell JD; Bruskewitz R; Walsh P; Andriole G; Lieber M; Holtgrewe HL; Albertsen P; Roehrborn CG; Nickel JC; Wang DZ; Taylor AM; Waldstreicher J
    N Engl J Med; 1998 Feb; 338(9):557-63. PubMed ID: 9475762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The long-term treatment of patients with benign prostatic hyperplasia using Proscar].
    Lopatkin NA; Roilans PJ; Stoner E
    Urol Nefrol (Mosk); 1996; (1):2-4. PubMed ID: 8659035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative evaluation of the effectiveness and safety of combined drug therapy of patients with benign prostatic hyperplasia with finasteride and alfuzozine].
    Loran OB; Pushkar' DIu; Rasner PI
    Urologiia; 2002; (1):19-22. PubMed ID: 11877966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of therapeutic effect of dibenyline, finasteride, and combination drugs for symptomatic benign prostatic hyperplasia.
    Kuo HC
    Urol Int; 1998; 60(2):85-91. PubMed ID: 9563145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of 5-alpha-reductase inhibitors in therapy of benign prostatic hyperplasia with mild to modern symptoms].
    Wirth MP; Helke C; Froschermaier SE
    Urologe A; 1997 Jan; 36(1):35-9. PubMed ID: 9123679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term results of proscar (finasteride, MSD) treatment of patients with benign prostatic hyperplasia].
    Tkachuk VN; Al'-Shukri SKh; Kornienko VI; Kuz'min IV
    Urol Nefrol (Mosk); 1998; (4):37-9. PubMed ID: 9727320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Finasteride in the treatment of benign prostatic hyperplasia.
    Ekman P; Andersen JT; Wolf H
    Acta Urol Belg; 1996 Mar; 64(1):IX-XII. PubMed ID: 8659328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Medical treatment of benign prostatic hyperplasia. The efficacy of finasteride depends on prostatic volume].
    Granados Loarca EA
    Arch Esp Urol; 1999 Apr; 52(3):201-8. PubMed ID: 10371735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.